Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
2.880
-0.692 (-19.37%)
At close: Mar 9, 2026, 4:00 PM EDT
2.980
+0.100 (3.47%)
After-hours: Mar 9, 2026, 7:55 PM EDT
RVPH Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 17 | 84 | 144 | 87 | 40 | 81 | |
| Market Cap Growth | -76.99% | -41.36% | 65.49% | 115.01% | -49.95% | 195.66% | |
| Enterprise Value | 4 | 79 | 139 | 64 | 7 | 114 | |
| Last Close Price | 2.88 | 36.20 | 103.00 | 85.00 | 57.80 | 174.90 | |
| PB Ratio | 3.05 | 103.76 | 25.14 | 10.35 | 1.41 | 14.77 | |
| P/TBV Ratio | 3.70 | 103.76 | 25.14 | 10.35 | 1.41 | 14.77 | |
| Debt / Equity Ratio | - | 0.56 | - | - | - | - | |
| Net Debt / Equity Ratio | -2.90 | -16.02 | -4.09 | -2.21 | -1.03 | -1.60 | |
| Net Debt / EBITDA Ratio | - | - | - | - | 2.94 | 3.60 | |
| Quick Ratio | 1.35 | 0.92 | 1.36 | 1.86 | 12.66 | 6.57 | |
| Current Ratio | 1.39 | 1.01 | 1.38 | 1.90 | 13.39 | 6.58 | |
| Return on Equity (ROE) | - | -916.17% | -556.38% | -152.43% | -49.91% | - | |
| Return on Assets (ROA) | -130.48% | -98.20% | -115.85% | -70.11% | -31.45% | -34.72% | |
| Return on Capital Employed (ROCE) | -499.00% | -3416.10% | -605.40% | -315.00% | -34.80% | -32.80% | |
| Earnings Yield | -135.24% | -35.49% | -27.31% | -32.53% | -21.09% | -4.69% | |
| Buyback Yield / Dilution | -72.64% | -39.28% | -21.94% | -31.95% | -383.10% | -10.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.